Street Calls of the Week
POMDOCTOR LIMITED (POM) completed its initial public offering of 5,000,004 American Depositary Shares at $4.00 per ADS, according to a company statement. The Chinese online medical services platform raised approximately $20 million in gross proceeds before underwriting discounts and expenses.
The ADSs began trading on the Nasdaq Global Market on October 8, 2025, under the ticker symbol "POM." Six ADSs represent one Class A ordinary share with a par value of $0.0001 per share.
The company granted underwriters an option to purchase up to 750,000 additional ADSs within 45 days at the public offering price, less underwriting discounts. Joseph Stone Capital, LLC served as the sole underwriter for the firm commitment offering.
The Securities and Exchange Commission declared the company’s Form F-1 registration statement effective on September 30, 2025. The registration statement was filed under number 333-285771.
POMDOCTOR operates an online medical services platform focused on chronic disease management in China. The company connects patients with doctors and pharmaceutical products through its internet hospital and pharmaceutical supply chain operations. According to Frost & Sullivan data cited by the company, POMDOCTOR ranked sixth in China’s internet hospital market based on contracted doctors in 2022.
The platform serves as an intermediary connecting users, pharmacies, suppliers, medical professionals and other healthcare participants. The company’s business model centers on chronic disease management and pharmaceutical services.